Sign in Subscribe
Nanotechnology

Advancing Cancer Treatment with Smart Nanoparticles: A Leap Forward in Precision Medicine

Strategic Insights

— 1 min read

Researchers from the University of Tartu have made a significant breakthrough in cancer treatment by developing smart nanoparticles that can target tumors with precision and effectiveness. According to a recent study, these nanoparticles have the potential to revolutionize cancer treatment by achieving a selective and efficient tumor accumulation, reducing off-target effects, and improving drug delivery efficiency.

Key Takeaways:

  • The development of smart nanoparticles for precision medicine in anticancer drug delivery and controlled release has the potential to revolutionize cancer treatment.
  • A critical challenge in achieving effective tumor accumulation and tissue penetration of nanoparticles is still unresolved, but affinity targeting strategies using ligands such as homing peptides and antibodies have shown promise.
  • Tumor-homing C-end Rule (CendR) peptides, such as prototypic iRGD peptide, represent a promising strategy for achieving selective targeting and enhanced tissue penetration.
  • This review highlights key milestones in the evolution of peptide-targeted nanoparticles, underscoring their role in advancing precision nanomedicine.
  • The research was conducted by researchers at the University of Tartu, including Tambet Teesalu, Antonella Rocchi, and Christian Celia.
  • The study was published in the journal ACS Pharmacology & Translational Science in 2025.
  • The research has the potential to improve the effectiveness and reduce the side effects of cancer treatment.

Statistics:

  • 2025: The year in which the study was published in the journal ACS Pharmacology & Translational Science.
  • 8(7):1919-1933: The publication details of the study in the journal ACS Pharmacology & Translational Science.
  • 50411: The zip code of the University of Tartu in Tartu, Estonia.
  • 1599: The page number of the news report in Nanotechnology Weekly.

Sources:

  • Advancing Cancer Targeted Nanotherapies with Tumor Homing Peptides. ACS Pharmacology & Translational Science, 2025;8(7):1919-1933.
  • NewsRx. University of Tartu Reports Findings in Cancer (Advancing Cancer Targeted Nanotherapies with Tumor Homing Peptides). Nanotechnology Weekly. July 28, 2025; p 1599.

Read more